Medicine and Dentistry
COVID-19
100%
Intensive Care Unit
66%
Infection
65%
Cohort Analysis
41%
Severe Acute Respiratory Syndrome Coronavirus 2
38%
Biological Marker
36%
Community-Acquired Pneumonia
32%
Ventilator-Associated Pneumonia
29%
Antibiotic Therapy
28%
Artificial Respiration
27%
Sepsis
25%
C Reactive Protein
25%
Intensive Care
23%
Bloodstream Infection
22%
Lower Respiratory Tract Infection
22%
Diagnosis
19%
Thrombocyte Transfusion
17%
Respiratory Failure
17%
Delirium
14%
Thrombocytopenia
14%
Pathogen
14%
Systematic Review
14%
Immunosuppressive Treatment
12%
Respiratory Tract Infection
12%
Disease
12%
Antimicrobial Therapy
11%
Serum Albumin
11%
Antibiotics
11%
Mixed Infection
11%
Intensive Care Medicine
10%
Lung Infection
10%
Acute Respiratory Distress Syndrome
10%
Cohort Effect
10%
Clinician
9%
Septic Shock
9%
Cardiovascular System
8%
Apoplexy
8%
Virus Infection
8%
Odds Ratio
8%
Multiple Organ Dysfunction Syndrome
7%
Malignant Neoplasm
7%
Procalcitonin
7%
Antibiotic Resistance
7%
Comorbidity
7%
Immune Response
7%
Observational Study
7%
Antifungal Agent
7%
Dyspnea
7%
Antiinfective Agent
6%
Lung
6%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
65%
Biological Marker
43%
Disease
34%
Coronavirinae
29%
Sepsis
28%
C Reactive Protein
24%
Community Acquired Pneumonia
18%
Antiinfective Agent
18%
Lower Respiratory Tract Infection
17%
SARS Coronavirus
16%
Cohort Study
15%
Infectious Agent
14%
Antibiotics
14%
Ventilator Associated Pneumonia
14%
Antimicrobial Therapy
13%
Antibiotic Resistance
10%
Delirium
10%
Pandemic
9%
Pharmacokinetics
9%
Superinfection
9%
Hydroxychloroquine
8%
Lung Infection
8%
Remdesivir
8%
Antifungal Agent
8%
Antibiotic Therapy
8%
Procalcitonin
8%
Serum Albumin
8%
Bloodstream Infection
8%
Observational Study
7%
Multiple Organ Failure
7%
Immunomodulating Agent
7%
Antimicrobial Resistance
7%
Invasive Aspergillosis
6%
Pharmacodynamics
6%
Comorbidity
6%
Dyspnea
5%
Respiratory Failure
5%
Adult Respiratory Distress Syndrome
5%
Hematologic Malignancy
5%
Clinical Trial
5%
Therapeutic Drug Monitoring
5%
Chloroquine
5%
Cytokine
5%
Placebo
5%
Disease Severity
5%
Respiratory Tract Infection
5%
Immunosuppressive Agent
5%
Antimalarial Agent
5%
Nursing and Health Professions
Intensive Care Unit
38%
Infection
30%
Intensive Care
19%
Disease
17%
Ventilator-Associated Pneumonia
15%
Severe Acute Respiratory Syndrome
14%
Cohort Analysis
14%
Delirium
13%
Bloodstream Infection
13%
Error
11%
Lower Respiratory Tract Infection
8%
Care (Medicine)
8%
Systematic Review
8%
Antibiotic Therapy
7%
Comorbidity
7%
Artificial Respiration
6%
Virus Infection
5%
Therapeutic Drug Monitoring
5%
Respiratory Failure
5%
Confidence Interval
5%
